Category Archives: Clinical Trials

A randomized, double-blind, placebo-controlled study of patients with PV using Infliximab 

The purpose of this trial is to determine the safety of infliximab (Remicade) for the treatment of patients with pemphigus vulgaris.  Secondary clinical endpoints include the number of days to cessation of new blister formation, the ability to reduce prednisone to 25% of the initial dose by week 18.

Northwestern University Feinberg School of Medicine’s Division of Immunotherapy is utilizing methods that allow the safe isolation, manipulation and preservation of population of stem cells and immune cells for therapeutic purposes. Currently DIAD collaborates with the Divisions of Rheumatology, Nephrology, Gastroenterology and Hematology/Oncology, and the Departments of Neurology and Transplant Surgery in innovation approaches and active protocols for the treatment of severe lupus, amyloidosis, multiple sclerosis, rheumatoid arthritis and post transplant Lymphoproliferative disorders and cancers.